AI-generated draft from CMS source. Review and verify clinical accuracy before use.
1. MEDICAL NECESSITY PATHWAY
Prior to scheduling CPT 64634 (Destruction by neurolytic agent of cervical or thoracic paravertebral facet joint nerve(s) at an additional facet joint level), documentation should confirm persistent pain directly attributable to a specific facet joint(s) in the cervical or thoracic spine. The medical record must include a detailed assessment correlating symptoms with anatomical pain generators and prior tests. Imaging and diagnostic procedures should support the clinical impression. The patient should have undergone appropriate conservative management or diagnostic blocks per LCD L38801 guidance. All findings and indications must be clearly documented prior to intervention.
2. CONSERVATIVE CARE / PRIOR TREATMENT SUPPORT
Source-stated requirement:
Refer to LCD L38801 for reasonable and necessary requirements and frequency limitations; documentation of failed conservative care is implied but specific timeframes are not clearly stated in the source.
Common documentation support, not explicitly required in source:
Patient has participated in conservative treatment including activity modification, physical therapy, pharmacologic pain management, and/or diagnostic medial branch nerve blocks without adequate sustained improvement.
Documentation supports why patient is not a candidate for radiofrequency ablation (RFA) if therapeutic injection is performed instead.
3. DIAGNOSIS / SYMPTOM SUPPORT
Patient reports chronic cervical or thoracic pain consistent with the documented diagnosis code related to facet joint pathology. The pain symptoms correlate with the anatomical facet joint level(s) targeted and have persisted despite conservative care measures. Functional limitations are documented in the medical record.
4. OBJECTIVE / IMAGING / EXAM CORRELATION
Imaging is useful and required for image guidance of the procedure (fluoroscopy or CT). Ultrasound guidance for this procedure is NOT covered.
Clinical findings, physical exam, and imaging studies (e.g., MRI, CT, or X-rays) correlate with the suspected facet joint pain generator. Diagnostic medial branch blocks or facet joint injections with documented response support the medical necessity of neurolytic nerve destruction.
5. PROCEDURE-SPECIFIC REQUIREMENTS
– CPT 64634 applies to destruction by neurolytic agent of cervical or thoracic facet joint nerve(s) at each additional facet joint (in addition to primary CPT 64633).
– Neurolytic destruction codes (64633, 64634) are reported per facet joint, not per nerve, regardless of number of nerves treated. Only one unit per joint allowed.
– Image guidance with fluoroscopy or CT is required; ultrasound guidance is not covered.
– Bilateral procedures should be reported with modifier -50 appended.
– For ambulatory surgery centers (ASCs), the facility reports separate lines with -RT and -LT modifiers.
– Non-thermal denervation methods (e.g., chemical, pulsed RF, or low grade thermal energy <80°C) must NOT be reported with these CPT codes; use of CPT 64999 for such non-thermal methods is non-covered.
– Moderate or deep sedation, general anesthesia, or monitored anesthesia care (MAC) are not medically reasonable during facet joint destruction unless clearly documented for RFA or cyst aspiration procedures.
– The number of injections or prior blocks required before CPT 64634 is not clearly stated in the source; however, diagnostic blocks are necessary to identify the pain generator per standard practice.
– Laterality and level documentation must be explicit.
6. READY-TO-PASTE AUTHORIZATION PARAGRAPH
Patient has diagnosis-supported chronic cervical or thoracic facet joint pain consistent with the requested CPT 64634 neurolytic destruction procedure. Symptoms are functionally limiting and have persisted despite appropriate conservative management and diagnostic interventions. Clinical assessment, imaging findings, and prior treatment history support that the requested facet joint neurolysis with image guidance is medically reasonable and necessary. The procedure will be performed following CMS LCD L38801 guidance, with precise documentation of facet joint level(s), laterality, and coding modifiers.
7. READY-TO-PASTE CHART NOTE LANGUAGE
Medical necessity reviewed. Patient continues to have clinically significant cervical/thoracic facet joint pain consistent with the documented diagnosis and suspected pain generator. Conservative care and diagnostic injections have failed to provide adequate relief. Based on the clinical evaluation, imaging, and prior treatment response, proceeding with neurolytic destruction of the facet joint nerve(s) at the documented levels is medically reasonable and necessary.
8. APPEAL / DENIAL SUPPORT LANGUAGE
The requested CPT 64634 procedure is supported by the patient's documented cervical/thoracic facet joint diagnosis, persistent functional limitation, and failed conservative care including diagnostic nerve blocks. Clinical and imaging correlation confirms the pain source is facetogenic. Documentation meets medical necessity criteria outlined in CMS LCD L38801. Denial should be reconsidered in light of the comprehensive clinical records and policy guidance provided.
9. RECORDS / ROI TO REQUEST
– Physical therapy progress notes
– Home exercise program documentation
– Medication management and trial records
– Diagnostic imaging reports (MRI, CT, X-ray)
– Prior diagnostic or therapeutic facet injections and medial branch block procedure notes including results and patient response
– Pain and function scoring documentation
– Previous operative or interventional procedure reports
– Referring and consulting provider assessments and notes
10. CAUTIONS / NOT COVERED
– Ultrasound guidance for facet joint neurolysis (CPT 64634) is not covered.
– Non-thermal facet joint denervation techniques using CPT 64999 are excluded and considered non-covered.
– Moderate or deep sedation, general anesthesia, or MAC without medical necessity documentation are not covered for this procedure.
– Biological or other non-designated substances injected into facet joints are non-covered and will cause claim denial.
– Frequency limits and coverage criteria are detailed in LCD L38801; adherence is required.
– Use of KX modifier is primarily for diagnostic injections and aberrant use during neurolytic procedures may trigger review.
– The number of prior injections or blocks before neurolytic destruction is not clearly stated in the source.
This CMS article (A58403, version 25) titled "Billing and Coding: Facet Joint Interventions for Pain Management" applies primarily to facet joint injections and neurolytic destruction procedures involving cervical/thoracic and lumbar/sacral spine regions. It refers to the related Local Coverage Determination (LCD) L38801 (version 23) for detailed reasonable and necessary coverage criteria and frequency limits. The article covers CPT codes primarily in the 64490-64495 range for diagnostic or therapeutic facet joint injections with imaging guidance (fluoroscopy or CT), and codes 64633-64636 for neurolytic destruction of facet joint nerves.
Coverage is organized by spinal region and injection level, with clear guidance that counting is by facet joint level (not nerves), and bilateral injections should be reported as one unit with modifier -50. Ultrasound-guided procedures and non-thermal denervation methods (e.g., pulsed RF) are not covered under these CPT codes and may be denied if reported improperly. Claims require valid ICD-10 diagnosis codes demonstrating conditions like spondylosis, ankylosing hyperostosis, or other dorsopathies without myelopathy or radiculopathy. No non-covered ICD-10 codes were listed, but biological or non-designated substances injected into facet joints will result in claim denial.
Providers must include the referring/ordering physician's name and NPI on claims, use appropriate modifiers (KX for initial diagnostic injections meeting criteria, 50 for bilateral procedures), and be aware of National Correct Coding Initiative (NCCI) edits. Use of moderate or deep sedation, general anesthesia, or monitored anesthesia care (MAC) is generally not considered reasonable during injections, except in special cases such as radiofrequency ablation (RFA) or facet cyst aspiration where medical necessity must be documented.
Documentation is required to support medical necessity and should include detailed patient assessment related to the complaint, relevant medical history, diagnostic test results, and signed and dated procedural or office visit reports.
Summary points:
– Coverage applies to fluoroscopically or CT-guided cervical/thoracic or lumbar/sacral facet joint injections and neurolytic destruction (codes 64490-64495, 64633-64636).
– Ultrasound-guided injections and non-thermal denervation with CPT code 64999 are not covered.
– Bilateral injections use modifier -50; initial diagnostic injections use modifier KX.
– Valid ICD-10 codes primarily include spondylosis and dorsopathies without myelopathy/radiculopathy.
– Biological injections into facet joints are non-covered.
– Moderate or deep sedation generally not covered; documentation required if used with RFA or cyst aspiration.
– Claims must include referring physician information and valid ICD-10 diagnoses.
– Thorough clinical documentation including assessment, history, test results, and signed notes is required for audit purposes.
This article and related LCD should be referenced for specific billing, coding, and coverage determination prior to submitting claims to Medicare.